Transcatheter Aortic Valve Replacement(TAVR) in a patient with multiple comorbidities, prioritizing minimally invasive intervention over surgical valve replacement

Abstract

Background: Severe aortic stenosis (AS) poses a significant clinical challenge, particularly in patients with multiple co-morbidities where conventional surgical intervention may carry prohibitively high peri-operative risks. Transcatheter Aortic Valve Replacement (TAVR) has emerged as a promising alternative for such patients, offering a minimally invasive approach with potentially favorable outcomes. This report aims to present a case illustrating the successful application of TAVR in managing severe AS in a high-risk patient with multiple co-morbidities.

Case Presentation: The patient in question is a 56-year-old female with a complex medical history, including ulcerative colitis and prolonged steroid use. During hospitalization for abdominal complaints unrelated to cardiovascular symptoms, diagnostic workup incidentally revealed severe asymptomatic aortic stenosis. The patient's clinical presentation was further complicated by the presence of multiple co-morbidities, rendering her unfit for traditional surgical aortic valve replacement (SAVR) due to the high peri-operative risk associated with her medical condition.

Management and Results: After careful consideration, it was decided that TAVR would be the preferred intervention. Post-procedure, the patient's recovery was uneventful, with no immediate complications observed.

Conclusion: This case report highlights the importance of TAVR and the expertise required to perform this procedure in treating severe aortic stenosis in high risk patients such as in our case with favorable outcomes.